NEURAVI

Neuravi is a medical-device brand and company focused on neurovascular intervention, particularly mechanical thrombectomy for acute ischemic stroke. Founded in Galway, Ireland, in 2010, the company developed the EmboTrap revascularization device, a stent-retriever-like platform designed to remove blood clots from cerebral arteries. Neuravi's technology was developed with a strong clinical and engineering focus on clot composition and retrieval performance, and the company built a presence in stroke-care markets in Europe and the United States. In 2017, Neuravi was acquired by Cerenovus, the neurovascular business of Johnson & Johnson MedTech (then part of Codman Neuro). The acquisition brought Neuravi's thrombectomy portfolio into a larger global neurovascular franchise that also includes coils, flow diverters, and other stroke-intervention products. Under Cerenovus, the EmboTrap platform continued to evolve, with later generations such as EmboTrap II and EmboTrap III, and Neuravi's Galway site remained an important research, development, and manufacturing location for neurovascular devices. Neuravi's brand identity is closely tied to stroke intervention: its products are used by neurointerventionalists to treat large-vessel occlusion strokes, a time-critical condition where rapid clot removal can reduce disability. The company's work sits at the intersection of interventional neuroradiology, biomedical engineering, and acute stroke care. Its website and corporate communications emphasize clinical evidence, device design, and training for stroke centers. As a subsidiary brand within Johnson & Johnson MedTech, Neuravi is not separately listed on a stock exchange; its parent, Johnson & Johnson, is publicly traded. The Neuravi name remains associated with the EmboTrap family and with the Galway neurovascular cluster, while commercial operations are integrated into Cerenovus's global stroke portfolio.

Neuravi was founded in Galway, Ireland, in 2010 as a neurovascular device company. Its founding team focused on mechanical thrombectomy, a technique for removing clots from cerebral arteries in acute ischemic stroke. At the time, stent-retriever thrombectomy was emerging as a major advance in stroke care, and Neuravi sought to improve clot retrieval through device design informed by clot composition and bench testing. The company developed the EmboTrap revascularization device, a stent-retriever platform with a segmented design intended to capture and remove thrombi from large vessels in the brain. Neuravi pursued clinical studies and regulatory clearances in Europe and the United States, building a customer base among neurointerventionalists and comprehensive stroke centers. In 2017, Neuravi was acquired by Cerenovus, the neurovascular franchise of Johnson & Johnson MedTech. The deal integrated Neuravi's thrombectomy technology into a broader portfolio that includes embolic coils, flow diversion, and other stroke-intervention products. Following the acquisition, the EmboTrap platform continued to be developed, with later generations such as EmboTrap II and EmboTrap III. Neuravi's Galway operations remained part of the Cerenovus network, contributing to research, development, and manufacturing of neurovascular devices. Under Johnson & Johnson MedTech, the Neuravi brand is primarily associated with the EmboTrap family and with stroke thrombectomy. The company's history reflects the growth of mechanical thrombectomy as a standard of care for large-vessel occlusion stroke and the consolidation of neurovascular device makers into larger medtech groups.

• 2017

  Neuravi acquired by Cerenovus, the neurovascular business of Johnson & Johnson MedTech.

• 2010

  Neuravi founded in Galway, Ireland.

Neurovascular thrombectomy and stroke-intervention technology, integrated into Cerenovus / Johnson & Johnson MedTech.

• EmboTrap revascularization device

  Stent-retriever-like thrombectomy device for removing clots in acute ischemic stroke.

• EmboTrap II

  Later-generation EmboTrap thrombectomy platform.

• EmboTrap III

  Further evolution of the EmboTrap thrombectomy platform.

1. 1NEURAVIwikidata.org
2. 2Neuravi official websiteneuravi.com